In models of LPS-induced septic shock, Collin et al. [67] and Kwon et al. [68] demonstrated that inhibition of ALOX5 and antagonism LTB4 receptors, respectively, reduced multiple LPS-induced effects. The gene discussed is ALOX5; the disease is Shock.